Sandra Sernbo

528 total citations
9 papers, 390 citations indexed

About

Sandra Sernbo is a scholar working on Molecular Biology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Sandra Sernbo has authored 9 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Genetics and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Sandra Sernbo's work include Chronic Lymphocytic Leukemia Research (3 papers), RNA modifications and cancer (2 papers) and Epigenetics and DNA Methylation (2 papers). Sandra Sernbo is often cited by papers focused on Chronic Lymphocytic Leukemia Research (3 papers), RNA modifications and cancer (2 papers) and Epigenetics and DNA Methylation (2 papers). Sandra Sernbo collaborates with scholars based in Sweden, Ireland and Uruguay. Sandra Sernbo's co-authors include Sara Ek, Michael Dictor, Mats Jerkeman, Carl Borrebaeck, Donal J. Brennan, Martin Sundberg, Torkel Wadström, Waleed Abu Al‐Soud, Carl Borrebaeck and Elin Andersson and has published in prestigious journals such as Blood, PLoS ONE and Molecular Cancer.

In The Last Decade

Sandra Sernbo

9 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sandra Sernbo Sweden	6	200	192	149	93	78	9	390
Agata M. Bogusz United States	13	152 0.8×	240 1.3×	204 1.4×	110 1.2×	54 0.7×	25	480
Alberto J. Arribas Switzerland	11	185 0.9×	220 1.1×	133 0.9×	136 1.5×	75 1.0×	50	430
Kranthi Kunkalla United States	12	282 1.4×	150 0.8×	220 1.5×	44 0.5×	59 0.8×	24	476
Ana I. Sáez Spain	7	148 0.7×	181 0.9×	194 1.3×	78 0.8×	39 0.5×	8	340
Bradley Long United States	10	94 0.5×	99 0.5×	122 0.8×	87 0.9×	84 1.1×	12	380
Isabel Romero-Camarero Spain	7	191 1.0×	175 0.9×	172 1.2×	73 0.8×	66 0.8×	11	412
T Kinoshita Japan	10	198 1.0×	104 0.5×	205 1.4×	107 1.2×	31 0.4×	17	437
Hisao Nagoshi Japan	12	299 1.5×	118 0.6×	136 0.9×	54 0.6×	84 1.1×	38	520
Jacob Haaber Denmark	8	105 0.5×	124 0.6×	192 1.3×	64 0.7×	30 0.4×	13	336
Eva Maria Murga Penas Germany	14	182 0.9×	239 1.2×	247 1.7×	196 2.1×	58 0.7×	31	550

Countries citing papers authored by Sandra Sernbo

Since Specialization

Citations

This map shows the geographic impact of Sandra Sernbo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Sernbo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Sernbo more than expected).

Fields of papers citing papers by Sandra Sernbo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Sernbo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Sernbo. The network helps show where Sandra Sernbo may publish in the future.

Co-authorship network of co-authors of Sandra Sernbo

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Sernbo. A scholar is included among the top collaborators of Sandra Sernbo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Sernbo. Sandra Sernbo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Mediavilla-Varela, Melanie, John J. Powers, Julio C. Chávez, et al.. (2025). Targeting S100A9-mediated inflammation: a novel therapeutic approach for CLL. Blood Advances. 9(20). 5219–5233. 1 indexed citations

Sernbo, Sandra, Juan Pablo Tosar, Daniel Prieto, et al.. (2022). TGF-β/SMAD Pathway Is Modulated by miR-26b-5p: Another Piece in the Puzzle of Chronic Lymphocytic Leukemia Progression. Cancers. 14(7). 1676–1676. 9 indexed citations

Prieto, Daniel, Sandra Sernbo, Cecilia Abreu, et al.. (2017). S100-A9 protein in exosomes from chronic lymphocytic leukemia cells promotes NF-κB activity during disease progression. Blood. 130(6). 777–788. 79 indexed citations

Nordström, Lena, Sandra Sernbo, Patrik Edén, et al.. (2014). SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma – a Nordic Lymphoma Group study. British Journal of Haematology. 166(1). 98–108. 96 indexed citations

Sernbo, Sandra, Carl Borrebaeck, Mathias Uhlén, Karin Jirström, & Sara Ek. (2013). Nuclear T-STAR Protein Expression Correlates with HER2 Status, Hormone Receptor Negativity and Prolonged Recurrence Free Survival in Primary Breast Cancer and Decreased Cancer Cell Growth In Vitro. PLoS ONE. 8(7). e70596–e70596. 2 indexed citations

Sernbo, Sandra, William M. Gallagher, Elton Rexhepaj, et al.. (2012). 152 The Tumour Suppressor SOX11 is Associated With Improved Cancer-specific Survival Among High Grade Epithelial Ovarian Cancers and is Silenced in Non-expressing in Vitro Models Through Reversible Promoter Methylation. European Journal of Cancer. 48. S37–S37. 1 indexed citations

Sernbo, Sandra, Donal J. Brennan, William M. Gallagher, et al.. (2011). The tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylation. BMC Cancer. 11(1). 405–405. 46 indexed citations

Sernbo, Sandra, Elin Andersson, Donal J. Brennan, et al.. (2010). SOX11 expression correlates to promoter methylation and regulates tumor growth in hematopoietic malignancies. Molecular Cancer. 9(1). 187–187. 59 indexed citations

Dictor, Michael, Sara Ek, Martin Sundberg, et al.. (2009). Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt's lymphoma. Haematologica. 94(11). 1563–1568. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact